Efficacy of COVID-19 Vaccination in People Living with HIV: A Public Health Fundamental Tool for the Protection of Patients and the Correct Management of Infection
Abstract
1. Introduction
2. Materials and Methods
Statistical Analyses
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- World Health Organization (WHO). Coronavirus (COVID-19) Dashboard. 2022. Available online: https://covid19.who.int (accessed on 22 July 2022).
- Lai, A.; Bergna, A.; Menzo, S.; Zehender, G.; Caucci, S.; Ghisetti, V.; Rizzo, F.; Maggi, F.; Cerutti, F.; Giurato, G.; et al. Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021. Virol. J. 2021, 18, 168. [Google Scholar] [CrossRef]
- Sanyaolu, A.; Okorie, C.; Marinkovic, A.; Patidar, R.; Younis, K.; Desai, P.; Hosein, Z.; Padda, I.; Mangat, J.; Altaf, M. Comorbidity and its Impact on Patients with COVID-19. SN Compr. Clin. Med. 2020, 2, 1069–1076. [Google Scholar] [CrossRef]
- Garbuglia, A.R.; Minosse, C.; Del Porto, P. mRNA- and Adenovirus-Based Vaccines against SARS-CoV-2 in HIV-Positive People. Viruses 2022, 14, 748. [Google Scholar] [CrossRef]
- Facciolà, A.; Micali, C.; Visalli, G.; Venanzi Rullo, E.; Russotto, Y.; Laganà, P.; Laganà, A.; Nunnari, G.; Di Pietro, A. COVID-19 and pregnancy: Clinical outcomes and scientific evidence about vaccination. Eur. Rev. Med. Pharmacol. Sci. 2022, 26, 2610–2626. [Google Scholar]
- D’Aleo, F.; Ceccarelli, M.; Venanzi Rullo, E.; Facciolà, A.; Di Rosa, M.; Pinzone, M.R.; Condorelli, F.; Visalli, G.; Picerno, I.; Berretta, M.; et al. Hepatitis C-related hepatocellular carcinoma: Diagnostic and therapeutic management in HIV-patients. Eur. Rev. Med. Pharmacol. Sci. 2017, 21, 5859–5867. [Google Scholar] [PubMed]
- Ceccarelli, M.; Rullo, E.V.; Facciolà, A.; Madeddu, G.; Cacopardo, B.; Taibi, R.; D’Aleo, F.; Pinzone, M.R.; Picerno, I.; di Rosa, M.; et al. Head and neck squamous cell carcinoma and its correlation with human papillomavirus in people living with HIV: A systematic review. Oncotarget 2018, 9, 17171–17180. [Google Scholar] [CrossRef][Green Version]
- D’Aleo, F.; Cama, B.A.V.; Paolucci, I.A.; Venanzi Rullo, E.; Condorelli, F.; Facciolà, A.; Di Francia, R.; Savasta, A.; Pinzone, M.R.; Picerno, I.; et al. New and old assumptions on lung cancer in people living with HIV. WCRJ 2018, 5, e1036. [Google Scholar]
- Facciolà, A.; Ceccarelli, M.; Venanzi Rullo, E.; d’Aleo, F.; Condorelli, F.; Visalli, G.; Cacopardo, B.; Pinzone, M.R.; di Rosa, M.; Nunnari, G.; et al. Prostate cancer in HIV-positive patients: A review of the literature. WCRJ 2018, 5, e1136. [Google Scholar]
- Ceccarelli, M.; Venanzi Rullo, E.; Vaccaro, M.; Facciolà, A.; d’Aleo, F.; Paolucci, I.A.; Cannavò, S.P.; Cacopardo, B.; Pinzone, M.R.; Pellicanò, G.F.; et al. HIV-associated psoriasis: Epidemiology, pathogenesis, and management. Dermatol. Ther. 2019, 32, e12806. [Google Scholar] [CrossRef] [PubMed]
- D’Andrea, F.; Ceccarelli, M.; Facciolà, A.; Nunnari, G.; Pellicanò, G.F.; Venanzi Rullo, E. Breast cancer in women living with HIV. Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 1158–1164. [Google Scholar]
- D’Andrea, F.; Pellicanò, G.F.; Venanzi Rullo, E.; d’Aleo, F.; Facciolà, A.; Micali, C.; Coco, M.; Visalli, G.; Picerno, I.; Condorelli, F.; et al. Cervical cancer in women living with HIV: A review of the literature. WCRJ 2019, 6, e1224. [Google Scholar]
- Pinzone, M.R.; Ceccarelli, M.; Venanzi Rullo, E.; Maresca, M.; Bruno, R.; Condorelli, F.; Di Rosa, M.; Madeddu, G.; Focà, E.; Calcagno, A.; et al. Circulating angiopoietin-like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease. Biomed Rep. 2019, 10, 140–144. [Google Scholar] [PubMed]
- Facciolà, A.; Venanzi Rullo, E.; Ceccarelli, M.; D’Andrea, F.; Coco, M.; Micali, C.; Cacopardo, B.; Marino, A.; Cannavò, S.P.; Di Rosa, M.; et al. Malignant melanoma in HIV: Epidemiology, pathogenesis, and management. Dermatol. Ther. 2020, 33, e13180. [Google Scholar] [CrossRef] [PubMed]
- Spieler, G.; Westfall, A.O.; Long, D.M.; Cherrington, A.; Burkholder, G.A.; Funderburg, N.; Raper, J.L.; Overton, E.T.; Willig, A.L. Trends in diabetes incidence and associated risk factors among people living with HIV in the current treatment era, 2008–2018. AIDS, 2022; Online ahead of print. [Google Scholar] [CrossRef] [PubMed]
- Milano, E.; Ricciardi, A.; Casciaro, R.; Pallara, E.; De Vita, E.; Bavaro, D.F.; Larocca, A.M.V.; Stefanizzi, P.; Tafuri, S.; Saracino, A. Immunogenicity and safety of the BNT162b2 COVID-19 mRNA vaccine in PLWH: A monocentric study in Bari, Italy. J. Med. Virol. 2022, 94, 2230–2236. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization (WHO). Clinical Features and Prognostic Factors of COVID-19 in People Living with HIV Hospitalized with Suspected or confirmed SARS-CoV-2 Infection. 2021. Available online: https://www.who.int/publications/i/item/WHO-2019-nCoV-Clinical-HIV-2021.1 (accessed on 30 July 2022).
- Blanco, J.L.; Ambrosioni, J.; Garcia, F.; Martínez, E.; Soriano, A.; Mallolas, J.; Miro, J.M. COVID-19 in Patients with HIV: Clinical Case Series. Lancet HIV 2020, 7, e314–e316. [Google Scholar] [CrossRef]
- Kanwugu, O.N.; Adadi, P. HIV/SARS-CoV-2 coinfection: A global perspective. J. Med. Virol. 2021, 93, 726–732. [Google Scholar] [CrossRef] [PubMed]
- Vizcarra, P.; Pérez-Elías, M.J.; Quereda, C.; Moreno, A.; Vivancos, M.J.; Dronda, F.; Casado, J.L.; Moreno, S.; Pérez-Elías, M.J.; Fortún, J.; et al. Description of COVID-19 in HIV-infected individuals: A single-centre, prospective cohort. Lancet HIV 2020, 7, e554–e564. [Google Scholar] [CrossRef]
- Wang, Y.; Feng, R.; Xu, J.; Shi, L.; Feng, H.; Yang, H. An updated meta-analysis on the association between HIV infection and COVID-19 mortality. AIDS 2021, 35, 1875–1878. [Google Scholar] [CrossRef]
- Wu, S.; Ming, F.; Xing, Z.; Zhang, Z.; Zhu, S.; Guo, W.; Zou, S.; Liu, J.; Liu, Y.; Liang, K. COVID-19 Vaccination Willingness Among People Living With HIV in Wuhan, China. Front. Public Health 2022, 10, 883453. [Google Scholar] [CrossRef] [PubMed]
- Ministero della Salute. Raccomandazioni ad Interim Sui Gruppi Target Della Vaccinazione anti-SARS-CoV-2/COVID-19. 2021. Available online: https://www.trovanorme.salute.gov.it/norme/renderPdf.spring?seriegu=SG&datagu=24/03/2021&redaz=21A01802&artp=1&art=1&subart=1&subart1=10&vers=1&prog=002 (accessed on 20 July 2022).
- Liu, Y.; Han, J.; Li, X.; Chen, D.; Zhao, X.; Qiu, Y.; Zhang, L.; Xiao, J.; Li, B.; Zhao, H. COVID-19 Vaccination in People Living with HIV (PLWH) in China: A Cross Sectional Study of Vaccine Hesitancy, Safety, and Immunogenicity. Vaccines 2021, 9, 1458. [Google Scholar] [CrossRef] [PubMed]
- El Chaer, F.; El Sahly, H.M. Vaccination in the adult patient infected with HIV: A review of vaccine efficacy and immunogenicity. Am. J. Med. 2019, 132, 437–446. [Google Scholar] [CrossRef] [PubMed]
- Guaraldi, G.; Marcotullio, S.; Maserati, R.; Gargiulo, M.; Milic, J.; Franconi, I.; Chirianni, A.; Andreoni, M.; Galli, M.; Lazzarin, A.; et al. The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic Clinical Management of HIV-1 Infected Persons. J. Frailty Aging 2019, 8, 10–16. [Google Scholar] [CrossRef] [PubMed]
- Levy, I.; Wieder-Finesod, A.; Litchevsky, V.; Biber, A.; Indenbaum, V.; Olmer, L.; Huppert, A.; Mor, O.; Goldstein, M.; Levin, E.G.; et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1. Clin. Microbiol. Infect. 2021, 27, 1851–1855. [Google Scholar] [CrossRef]
- Madhi, S.A.; Koen, A.L.; Izu, A.; Fairlie, L.; Cutland, C.L.; Baillie, V.; Padayachee, S.D.; Dheda, K.; Barnabas, S.L.; Bhorat, Q.E.; et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: An interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial. Lancet HIV 2021, 8, e568–e580. [Google Scholar] [CrossRef]
- Menson, E.N.; Mellado, M.J.; Bamford, A.; Castelli, G.; Duiculescu, D.; Marczyńska, M.; Navarro, M.; Scherpbier, H.J.; Heath, P.T.; Paediatric European Network for Treatment of AIDS (PENTA) Vaccines Group. Guidance on vaccination of HIV-infected children in Europe. HIV Med. 2012, 13, 333–336. [Google Scholar] [CrossRef]
- Hassold, N.; Brichler, S.; Ouedraogo, E.; Leclerc, D.; Carroue, S.; Gater, Y.; Alloui, C.; Carbonnelle, E.; Bouchaud, O.; Mechai, F.; et al. Impaired antibody response to COVID-19 vaccination in advanced HIV infection. AIDS 2022, 36, F1–F5. [Google Scholar] [CrossRef]
- Ambrosioni, J.; Blanco, J.L.; Reyes-Urueña, J.M.; Davies, M.A.; Sued, O.; Marcos, M.A.; Martínez, E.; Bertagnolio, S.; Alcamí, J.; Miro, J.M.; et al. Overview of SARS-CoV-2 infection in adults living with HIV. Lancet HIV 2021, 8, e294–e305. [Google Scholar] [CrossRef]
- Geretti, A.M.; Stockdale, A.J.; Kelly, S.H.; Cevik, M.; Collins, S.; Waters, L.; Villa, G.; Docherty, A.; Harrison, E.M.; Turtle, L.; et al. Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study. Clin. Infect. Dis. 2021, 73, e2095–e2106. [Google Scholar] [CrossRef]
- Bhaskaran, K.; Rentsch, C.T.; MacKenna, B.; Schultze, A.; Mehrkar, A.; Bates, C.J.; Eggo, R.M.; Morton, C.E.; Bacon, S.C.J.; Inglesby, P.; et al. HIV infection and COVID-19 death: A population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV 2021, 8, e24–e32. [Google Scholar] [CrossRef]
- Tesoriero, J.M.; Swain, C.E.; Pierce, J.L.; Zamboni, L.; Wu, M.; Holtgrave, D.R.; Gonzalez, C.J.; Udo, T.; Morne, J.E.; Hart-Malloy, R.; et al. COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State. JAMA Netw. Open. 2021, 4, e2037069. [Google Scholar] [CrossRef] [PubMed]
- Spinelli, M.A.; Lynch, K.L.; Yun, C.; Glidden, D.V.; Peluso, M.J.; Henrich, T.J.; Gandhi, M.; Brown, L.B. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralization antibody titres after infection, compared by HIV status: A matched case-control observational study. Lancet HIV 2021, 8, e334–e341. [Google Scholar] [CrossRef]
- Fehr, D.; Lebouché, B.; Ruppenthal, L.; Brownc, M.; Obasc, N.; Bourbonnière, E.; Girouard, J.; Massicotte, A.; Jenabian, M.A.; Almomen, A.A.; et al. Characterization of people living with HIV in a Montreal-based tertiary care center with COVID-19 during the first wave of the pandemic. AIDS Care 2022, 34, 663–669. [Google Scholar] [CrossRef] [PubMed]
- Sheth, A.N.; Althoff, K.N.; Brooks, J.T. Influenza susceptibility, severity, and shedding in HIV-infected adults: A review of the literature. Clin. Infect. Dis. 2011, 52, 219–227. [Google Scholar] [CrossRef]
- Shinde, V.; Bhikha, S.; Hoosain, Z.; Archary, M.; Bhorat, Q.; Fairlie, L.; Lalloo, U.; Masilela, M.S.L.; Moodley, D.; Hanley, S.; et al. Efficacy of NVX-CoV2373 COVID-19 vaccine against the B.1.351 variant. N. Engl. J. Med. 2021, 384, 1899–1909. [Google Scholar] [CrossRef] [PubMed]
- Frater, J.; Ewer, K.J.; Ogbe, A.; Pace, M.; Adele, S.; Adland, E.; Alagaratnam, J.; Aley, P.K.; Ali, M.; Ansari, M.A.; et al. Oxford COVID Vaccine Trial Group. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: A single-arm substudy of a phase 2/3 clinical trial. Lancet HIV 2021, 8, e474–e485. [Google Scholar] [CrossRef]
- Ogbe, A.; Pace, M.; Bittaye, M.; Tipoe, T.; Adele, S.; Alagaratnam, J.; Aley, P.K.; Ansari, M.A.; Bara, A.; Broadhead, S.; et al. Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV. JCI Insight 2022, 7, e157031. [Google Scholar] [CrossRef]
- Woldemeskel, B.A.; Karaba, A.H.; Garliss, C.C.; Beck, E.J.; Wang, K.H.; Laeyendecker, O.; Cox, A.L.; Blankson, J.N. The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living with HIV. Clin. Infect. Dis. 2022, 74, 1268–1270. [Google Scholar] [CrossRef]
- Ruddy, J.A.; Boyarsky, B.J.; Bailey, J.R.; Karaba, A.H.; Garonzik-Wang, J.M.; Segev, D.L.; Durand, C.M.; Werbel, W.A. Safety and antibody response to two-dose SARSCoV-2 messenger RNA vaccination in persons with HIV. AIDS 2021, 35, 2399–2401. [Google Scholar] [CrossRef]
- González de Aledo, M.; Cañizares, A.; Vázquez-Rodríguez, P.; Castro, Á.; Moldes, L.; López, S.; Míguez, E.; Bou, G.; Mena, Á. Safety and Immunogenicity of SARS-CoV-2 vaccines in people with HIV. AIDS 2022, 36, 691–695. [Google Scholar] [CrossRef]
- Riou, C.; du Bruyn, E.; Stek, C.; Daroowala, R.; Goliath, R.T.; Abrahams, F.; Said-Hartley, Q.; Allwood, B.W.; Hsiao, N.Y.; Wilkinson, K.A.; et al. Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection. J. Clin. Investig. 2021, 131, JCI149125. [Google Scholar] [CrossRef] [PubMed]
- Ibarrondo, F.J.; Fulcher, J.A.; Goodman-Meza, D.; Elliott, J.; Hofmann, C.; Hausner, M.A.; Ferbas, K.G.; Tobin, N.H.; Aldrovandi, G.M.; Yang, O.O. Rapid decay of anti–SARS-CoV-2 antibodies in persons with mild COVID-19. N. Engl. J. Med. 2020, 383, 1085–1087. [Google Scholar] [CrossRef] [PubMed]
- Wang, M.; Luo, L.; Bu, H.; Xia, H. One case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a low CD4+ T-cell count. Int. J. Infect. Dis. 2020, 96, 148–150. [Google Scholar] [CrossRef] [PubMed]
- Touizer, E.; Alrubayyi, A.; Rees-Spear, C.; Fisher-Pearson, N.; Griffith, S.A.; Muir, L.; Pellegrino, P.; Waters, L.; Burns, F.; Kinloch, S.; et al. Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV. Lancet HIV 2021, 8, e317–e318. [Google Scholar] [CrossRef]
- Facciolà, A.; Visalli, G.; Antonuccio, G.; Fedele, F.; Nunnari, G.; Pellicanò, G.F.; Picerno, I.; Di Pietro, A. Epidemiology of the new HIV infections in a large university hospital of Southern Italy: The importance of increasing the culture of the HIV screening test in the prevention of late diagnosis. Epidemiol. Prev. 2020, 44, 235–242. [Google Scholar] [PubMed]
- Squeri, R.; Levita, A.; Intelisano, R.; Costa, G.B.; Mancuso, G.; Grasso, L.; D’Amato, S.; Mazzitelli, F.; Squeri, A.; Midiri, A.; et al. Correct management and low rate of contagiousness of healthcare workers in a University Hospital in Southern Italy: From contact tracing to serological investigation. Acta Biomed. 2020, 91, 79–86. [Google Scholar]
- D’Amato, S.; Squeri, R.; La Fauci, V.; Pantò, G.; Esposito, E.M.; Denaro, F.; Visalli, G.; Giunta, I.; Venuto, R.; Privitera, A.; et al. COVID-19 serological evaluation in a cohort of Vaccinated and Seropositive healthcare workers. Acta Biomed. 2021, 92, e2021415. [Google Scholar]
- Day, C.L.; Kaufmann, D.E.; Kiepiela, P.; Brown, J.A.; Moodley, E.S.; Reddy, S.; Mackey, E.W.; Miller, J.D.; Leslie, A.J.; DePierres, C.; et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006, 443, 350–354. [Google Scholar] [CrossRef]
- Fenwick, C.; Joo, V.; Jacquier, P.; Noto, A.; Banga, R.; Perreau, M.; Pantaleo, G. T-cell exhaustion in HIV infection. Immunol. Rev. 2019, 292, 149–163. [Google Scholar] [CrossRef]
- Kurachi, M. CD8+ T cell exhaustion. Semin. Immunopathol. 2019, 41, 327–337. [Google Scholar] [CrossRef] [PubMed]
- McLane, L.M.; Wherry, E.J. CD8 T cell exhaustion During chronic viral infection and Cancer. Annu. Rev. Immunol. 2019, 37, 457–495. [Google Scholar] [CrossRef] [PubMed]
- Venanzi Rullo, E.; Pinzone, M.R.; Cannon, L.; Weissman, S.; Ceccarelli, M.; Zurakowski, R.; Nunnari, G.; O’Doherty, U. Persistence of an intact HIV reservoir in phenotypically naive T cells. JCI Insight. 2020, 5, e133157. [Google Scholar] [CrossRef] [PubMed]
- Visalli, G.; Paiardini, M.; Chirico, C.; Cervasi, B.; Currò, M.; Ferlazzo, N.; Bertuccio, M.P.; Favaloro, A.; Pellicanò, G.; Sturniolo, G.; et al. Intracellular accumulation of cell cycle regulatory proteins and nucleolin re-localization are associated with pre-lethal ultrastructural lesions in circulating T lymphocytes: The HIV-induced cell cycle dysregulation revisited. Cell Cycle 2010, 9, 2130–2140. [Google Scholar] [CrossRef]
- Visalli, G.; Bertuccio, M.P.; Currò, M.; Pellicanò, G.; Sturniolo, G.; Carnevali, A.; Spataro, P.; Ientile, R.; Picerno, I.; Cavallari, V.; et al. Bioenergetics of T cell activation and death in HIV type 1 infection. AIDS Res. Hum. Retrovir. 2012, 28, 1110–1118. [Google Scholar] [CrossRef]
- Bengsch, B.; Johnson, A.L.; Kurachi, M.; Odorizzi, P.M.; Pauken, K.E.; Attanasio, J.; Stelekati, E.; McLane, L.M.; Paley, M.A.; Delgoffe, G.M.; et al. Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8 + T cell exhaustion. Immunity 2016, 45, 358–373. [Google Scholar] [CrossRef] [PubMed]
- Desdin-Mico, G.; Soto-Heredero, G.; Mittelbrunn, M. Mitochondrial activity in T cells. Mitochondrion 2018, 41, 51–57. [Google Scholar] [CrossRef]
- D’Amato, S.; Pellicanò, G.F.; Nunnari, G.; Fedele, F.; Mazzitelli, F.; D’Andrea, F.; Maisano, D.; Squeri, R.; Genovese, C. Management care improvement of people living with HIV: Definition of a targeted clinical pathway in a University Hospital of South Italy. Acta Biomed. 2021, 92, e2021244. [Google Scholar]
- D’Andrea, F.; Ceccarelli, M.; Venanzi Rullo, E.; Facciolà, A.; d’Aleo, F.; Cacopardo, B.; Iacobello, C.; Costa, A.; Altavilla, G.; Pellicanò, G.F.; et al. Cancer screening in HIV-infected patients: Early diagnosis in a high-risk population. WCRJ 2018, 5, e1130. [Google Scholar]
- Ceccarelli, M.; Condorelli, F.; Venanzi Rullo, E.; Pellicanò, G.F. Editorial—Improving access and adherence to screening tests for cancers: A new, though old, challenge in the HIV epidemics. WCRJ 2018, 5, e1030. [Google Scholar]
- Visalli, G.; Cosenza, B.; Mazzù, F.; Bertuccio, M.P.; Spataro, P.; Pellicanò, G.F.; Di Pietro, A.; Picerno, I.; Facciolà, A. Knowledge of sexually transmitted infections and risky behaviours: A survey among high school and university students. J. Prev. Med. Hyg. 2019, 60, E84–E92. [Google Scholar] [PubMed]
- Venanzi Rullo, E.; Ceccarelli, M.; Condorelli, F.; Facciolà, A.; Visalli, G.; D’Aleo, F.; Paolucci, I.; Cacopardo, B.; Pinzone, M.R.; Di Rosa, M.; et al. Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors (Review). Mol. Med. Rep. 2019, 19, 1987–1995. [Google Scholar] [CrossRef] [PubMed]
PLWH (n = 84) | ||
Whole sample | % | Mean age |
Men | 85.1 | 49.2 ± 12.4 (min. 25; max. 74) |
Women | 14.9 | 39.1 ± 14.7 (min. 21; max. 67) |
Nationality | ||
Italians | 90.4 | 49.3 ± 12.3 (min. 25; max. 74) |
Foreigners | 9.6 | 35.5 ± 14.2 (min. 21; max. 67) |
Gender/Nationality | ||
Italian men | 94.7 | 49.7 ± 12.3 (min. 25; max. 74) |
Italian women | 5.3 | 42.8 ± 11.1 (min. 28; max. 57) |
Foreign men | 25.0 | 32.0 ± 1.6 (min. 30; max. 34) |
Foreign women | 75.0 | 36.7 ± 16.2 (min. 21; max. 67) |
CONTROL GROUP (n = 64) | ||
Whole sample | % | Mean age |
Men | 80.5 | 43.3 ± 12.2 (min. 27; max. 67) |
Women | 19.5 | 37.0 ± 10.1 (min. 29; max. 58) |
TND (%) | WBC (Mean Value in Absolute Counts/mm3 ± SD) | CD4+ (Mean Value in Absolute Counts/mm3 ± SD) | CD4+/CD8+ Ratio (Mean Value in Absolute Counts/mm3 ± SD) | |
Nationality | ||||
Italians | 86.8 | 7002 ± 2262 (min. 700; max. 12,500) | 827 ± 387 (min. 10; max. 1917) | 1.08 ± 0.5 (min. 0.02; max. 2.36) |
Foreigners | 87.5 | 6371 ± 1897 (min. 3600; max. 9970) | 878 ± 223 (min. 492; max. 1069) | 1.55 ± 0.6 (min. 0.73; max. 2.56) |
Gender/Nationality | ||||
Italian men | 86.1 | 6936 ± 2208 (min. 700; max. 12,500) | 814 ± 386 (min. 10; max. 1917) | 1.07 ± 0.5 (min. 0.02; max. 2.36) |
Italian women | 75.0 | 8183 ± 2812 (min. 3700; max. 10,600) | 1055 ± 345 (min. 541; max. 1482) | 1.18 ± 0.64 (min. 0.25; max. 2.05) |
Foreign men | 100.0 | 8785 ± 1185 (min. 7600; max. 9970) | 1025 ± 44 (min. 980; max. 1069) | 1.74 ± 0.11 (min. 1.63; max. 1.85) |
Foreign women | 83.3 | 5567 ± 1261 (min. 3600; max. 7200) | 830 ± 237 (min. 492; max. 1056) | 1.49 ± 0.67 (min. 0.73; max. 2.56) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Facciolà, A.; D’Amato, S.; Calimeri, S.; Giudice, D.L.; Micali, C.; Russotto, Y.; Venanzi Rullo, E.; Nunnari, G.; Squeri, R.; Pellicanò, G.F. Efficacy of COVID-19 Vaccination in People Living with HIV: A Public Health Fundamental Tool for the Protection of Patients and the Correct Management of Infection. Infect. Dis. Rep. 2022, 14, 784-793. https://doi.org/10.3390/idr14050080
Facciolà A, D’Amato S, Calimeri S, Giudice DL, Micali C, Russotto Y, Venanzi Rullo E, Nunnari G, Squeri R, Pellicanò GF. Efficacy of COVID-19 Vaccination in People Living with HIV: A Public Health Fundamental Tool for the Protection of Patients and the Correct Management of Infection. Infectious Disease Reports. 2022; 14(5):784-793. https://doi.org/10.3390/idr14050080
Chicago/Turabian StyleFacciolà, Alessio, Smeralda D’Amato, Sebastiano Calimeri, Daniela Lo Giudice, Cristina Micali, Ylenia Russotto, Emmanuele Venanzi Rullo, Giuseppe Nunnari, Raffaele Squeri, and Giovanni Francesco Pellicanò. 2022. "Efficacy of COVID-19 Vaccination in People Living with HIV: A Public Health Fundamental Tool for the Protection of Patients and the Correct Management of Infection" Infectious Disease Reports 14, no. 5: 784-793. https://doi.org/10.3390/idr14050080
APA StyleFacciolà, A., D’Amato, S., Calimeri, S., Giudice, D. L., Micali, C., Russotto, Y., Venanzi Rullo, E., Nunnari, G., Squeri, R., & Pellicanò, G. F. (2022). Efficacy of COVID-19 Vaccination in People Living with HIV: A Public Health Fundamental Tool for the Protection of Patients and the Correct Management of Infection. Infectious Disease Reports, 14(5), 784-793. https://doi.org/10.3390/idr14050080